REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
06/11/2020 08:45
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201106:nBw7QFhMJa
Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
FORM 8.3 - Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 03 November 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,911,532 2.26% 686,362 0.53%
(2) Derivatives (other than options):
366,484 0.28% 739,005 0.57%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,278,016 2.54% 1,425,367 1.11%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 183.9900 USD
Purchase 1 183.2400 USD
Purchase 1 181.8800 USD
Purchase 1 181.5500 USD
Purchase 3 183.6433 USD
Purchase 4 183.1325 USD
Purchase 12 182.6098 USD
Purchase 41 181.2400 USD
Purchase 50 181.2652 USD
Purchase 100 183.5200 USD
Purchase 101 181.4305 USD
Purchase 133 183.2877 USD
Purchase 627 181.9100 USD
Purchase 646 181.7728 USD
Purchase 681 181.1417 USD
Purchase 902 183.5700 USD
Purchase 1,000 181.6330 USD
Purchase 1,276 183.0913 USD
Purchase 1,897 183.3951 USD
Purchase 2,600 182.2088 USD
Purchase 3,838 181.9731 USD
Purchase 4,508 182.2419 USD
Purchase 6,242 182.0108 USD
Purchase 7,319 182.2122 USD
Purchase 10,000 181.7455 USD
Purchase 42,723 180.6718 USD
Purchase 453,241 180.5100 USD
Sale 4 183.3075 USD
Sale 12 181.6516 USD
Sale 20 182.0230 USD
Sale 100 183.6500 USD
Sale 162 181.3164 USD
Sale 186 181.1927 USD
Sale 194 183.0267 USD
Sale 200 182.6600 USD
Sale 202 181.2793 USD
Sale 217 182.1878 USD
Sale 247 181.1209 USD
Sale 273 183.4108 USD
Sale 300 183.9033 USD
Sale 300 181.7283 USD
Sale 304 182.3488 USD
Sale 411 181.8400 USD
Sale 413 181.3639 USD
Sale 436 181.2898 USD
Sale 445 181.3053 USD
Sale 567 181.0994 USD
Sale 626 181.1259 USD
Sale 701 181.3275 USD
Sale 902 183.5700 USD
Sale 1,200 183.0300 USD
Sale 1,400 181.7101 USD
Sale 1,636 181.6461 USD
Sale 2,207 182.6758 USD
Sale 3,444 181.7029 USD
Sale 3,712 182.1259 USD
Sale 3,994 180.5144 USD
Sale 4,355 182.2920 USD
Sale 6,609 182.2584 USD
Sale 10,167 181.9171 USD
Sale 15,500 180.5247 USD
Sale 28,596 180.8136 USD
Sale 448,214 180.5100 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 6 Nov 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201106005159/en/
(https://www.businesswire.com/news/home/20201106005159/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - DCC PLC Barclays PLC - Holding in Company TR-1
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Unite Group PLC - Form 8.3 UNITE GROUP PLC, THE
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 - SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Bakkavor Group PLC - Form 8.3 BAKKAVOR GROUP PLC
Announcement